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Abstract
Background: MicroRNAs (miRNAs) are short non-coding RNA molecules that regulate mRNA transcript levels and
translation. Deregulation of microRNAs is indicated in a number of diseases and microRNAs are seen as a
promising target for biomarker identification and drug development. miRNA expression is commonly measured by
microarray or real-time polymerase chain reaction (RT-PCR). The findings of RT-PCR data are highly dependent on
the normalization techniques used during preprocessing of the Cycle Threshold readings from RT-PCR. Some of the
commonly used endogenous controls themselves have been discovered to be differentially expressed in various
conditions such as cancer, making them inappropriate internal controls.
Methods: We demonstrate that RT-PCR data contains a systematic bias resulting in large variations in the Cycle
Threshold (CT) values of the low-abundant miRNA samples. We propose a new data normalization method that
considers all available microRNAs as endogenous controls. A weighted normalization approach is utilized to allow
contribution from all microRNAs, weighted by their empirical stability.
Results: The systematic bias in RT-PCR data is illustrated on a microRNA dataset obtained from primary cutaneous
melanocytic neoplasms. We show that through a single control parameter, this method is able to emulate other
commonly used normalization methods and thus provides a more general approach. We explore the consistency
of RT-PCR expression data with microarray expression by utilizing a dataset where both RT-PCR and microarray
profiling data is available for the same miRNA samples.
Conclusions: A weighted normalization method allows the contribution of all of the miRNAs, whether they are
highly abundant or have low expression levels. Our findings further suggest that the normalization of a particular
miRNA should rely on only miRNAs that have comparable expression levels.
microRNA RT-PCR, Normalization, Microarray
Background
MicroRNAs (miRNAs) are short non-coding RNA
sequences that average 22 nucleotides in length [1-3].
This class of RNAs is distinct from other short sequence
RNA types such as siRNA and snRNA. The first RNA of
this class was identified in C. Elegans in 1993 [4]. How-
ever, miRNAs were not recognized as a special class of
RNAs until a decade ago [5]. To date, all animal and
plant species have been found to express miRNAs [6]. At
this time approximately 1000 miRNA sequences have
been identified in the human microribonucleome [7].
miRNA sequences are highly evolutionarily conserved
among mammals [4,8-12]. Approximately 80% of known
miRNA genes are found in intronic regions of the gen-
ome [13,14]. miRNAs are involved in many biological
processes by influencing the regulation of specific target
genes, generally resulting in the down-regulation of those
target genes. There are two postulated methods by which
miRNAs act on their target genes. If the miRNA binds
with an mRNA transcript and they exhibit high comple-
mentarity, it will cause the degradation of the mRNA. If
the miRNA binds with incomplete complementarity then
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it causes translational repression of the mRNA. In plants
the primary mechanism of action of miRNAs is mRNA
transcript degradation, while in animals, translational
repression is more common [6]. An estimated 60% of
mammalian mRNAs are targeted by one or more miR-
NAs [10,12].
miRNAs have been discovered to play a role in many
diseases and pathologies [2,10,13,15,16]. The role of miR-
NAs in cancer has been examined and several miRNAs
have been found to regulate tumor-related genes
[1-3,10,13,17-19]. In fact, more than half of all miRNA
genes are located in cancer-associated regions of the gen-
ome or in fragile sites [3,13]. As a result, therapeutic
applications of miRNAs are being investigated. Further-
more, due to the link between many miRNAs and cancer,
these RNA molecules are being investigated as potential
cancer biomarkers. The fact that some miRNAs can be
found extracellularly and maintain their stability in the
extracellular environment facilitates their usage as bio-
markers [10].
There are two main tools used to quantify the expres-
sion of miRNAs: microarrays and real-time polymerase
chain reaction (RT-PCR). RT-PCR returns the number of
cycles that the samples underwent before they were
detected, reported as a value known as the Cycle Thresh-
old (CT). The CT values vary logarithmically with expres-
sion levels. There are several methods of normalizing the
data and calculating the fold-change of each gene between
samples. For convenience, in this presentation the terms,
“miRNA” and “gene,” are used interchangeably in the con-
text of RT-PCR. ΔCT values are calculated by subtracting
the CT value of the endogenous control for a given sample
(or the mean of the CT values of the endogenous controls
if more than one exist) from the CT value of the gene for
the given sample. In the calculation of ΔCT values we
refer to the number subtracted from the raw CT values of
each gene as the CT0. The ΔΔCT is calculated by subtract-
ing the ΔCT of an experimental sample from a control
sample. Fold change is calculated by raising 2 to the
power of the negative ΔΔCT value, since CT values are
related to the amount of miRNA or gene logarithmically
[20]. The relationship between CT, ΔCT, ΔΔCT, and Fold
Change (FC) are given by the equations below.
CT = CT − CT0 (1)
ΔΔCT = ΔCT − ΔCTcontrol (2)
FC = 2−ΔΔCT (3)
Theoretically, endogenous controls are selected
because they have low variance in their expression levels
across samples. In the case of miRNAs, the endogenous
controls are typically recommended by the manufacturer
of the miRNA kit used in the PCR. Some of the most
commonly used endogenous controls are RNU44,
RNU48, and U6 [17]. However, the usage of these endo-
genous controls is problematic, because even though
these endogenous controls have stable expression levels
in normal tissue samples, they have been found to be dif-
ferentially expressed in cancerous tissue compared with
normal tissue [20].
Directly applying this method can lead to misleading
results if the CT values in the data are not normalized.
There are several commonly used methods for miRNA
normalization, including: quantile normalization, median
normalization, and cyclic loess. Quantile normalization
involves sorting the expression values of each gene in a
given sample in order from least to greatest. This is done
for each sample in the study. The vectors of the sorted
CT values for each sample are combined into a matrix.
The mean of each row of the matrix is calculated. The
CT value in each element in each row is replaced with
the mean of the entire row. In the case of median quan-
tile normalization the median of the row is used instead
of the mean. The CT values in each sample are then rear-
ranged back into their original order. This causes the dis-
tribution of CT values across all samples to assume the
same shape, which will minimize the variance except for
that resulting from the experimental condition beings
studied [21,22].
Median normalization shifts the CT values in each
sample such that the median CT value of each sample is
the same. The median of each plate should be deter-
mined, and the medians of all plates should be arranged
in a vector and sorted to determine the median of the
medians. In each plate the difference between the median
of the sample and the overall median should be sub-
tracted from the CT value of each gene [9].
In cyclic loess normalization, pairs of plates are consid-
ered. For all pairs of plates the difference of the log of the
CT for each gene is represented by M, and the average of
each gene of the log of the expression values is repre-
sented by A. Then a loess curve is fit by regression of M
on A which results in a fitting vector F. The genes in the
first sample are adjusted by adding half the F value corre-
sponding to the log of the CT for each gene. In the second
sample half the F value is subtracted from the log CT of
the gene [9,21].
A number of normalization methods developed for
microarrays have been applied to RT-PCR experiments.
These methods assume that all miRNAs present in the
organism are being profiled in the experiment. While
microarrays can profile all miRNAs encoded in a gen-
ome, this assumption does not hold for RT-PCR experi-
ments which typically only profile a few hundred
miRNAs at a given time [23]. Mar et al. investigated the
use of quantile normalization as well as rank-invariant
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set normalization [24]. In rank-invariant set normaliza-
tion genes are ranked by their expression for each sam-
ple and the ranked list is compared to the ranked list of
genes for a reference sample. Genes are considered to
be rank-invariant if they have similar ranks in the refer-
ence sample and the experimental sample. All experi-
mental samples are compared to the reference sample
and an intersection of these lists is used to identify the
rank-invariant genes which can then be used for nor-
malization [24]. Deo et al. compared several normaliza-
tion methods and concluded that data-driven methods
performed best. They compared normalization by endo-
genous controls, using the mean as a pseudo-control,
and two different methods of quantile normalization.
They concluded that quantile normalization performed
the best despite the fact that using the mean as an
endogenous control produced lower standard deviation
[23].
One of the main problems with RT-PCR that remains
as yet unaddressed by current normalization methods
is the systematic bias present within the data. We
observe that standard deviation increases as CT values
increase. We believe that the most likely cause of this
observation is the assumption that the PCR magnifica-
tion at each cycle is an exact doubling of the expres-
sion levels is inaccurate. There seems to be an
accumulation of an expression-level specific rate-limit-
ing effect. As a result, a small difference in the size of
the initial sample being amplified causes larger varia-
tions in the CT values of the less abundant microRNA
molecules. Consequently, using endogenous controls,
which are usually chosen from highly expressed micro-
RNAs, for normalization becomes inappropriate for the
less-abundant microRNAs. Even quantile normalization
has been observed to produce more variance at high
CT values than was present in the original raw data
[24]. One potential solution is to use the mean expres-
sion values of all genes in a sample as the endogenous
control, as proposed by Mestdagh et al. [15], and calcu-
late ΔCT by subtracting this mean CT value from the
CT value of all genes in the sample. However, this
approach is not ideal because the mean of the entire
sample is sensitive to fluctuating genes as well as unde-
tected genes which have high CT values. As a result,
the mean-value normalization method is dominated by
the large fluctuations of the less-abundant microRNAs
and may cause spurious differential expression levels
for otherwise stable microRNAs. In this study, we pro-
pose a method of using a weighted mean as an artificial
endogenous control to calculate ΔCT values. The stan-
dard deviation of a microRNA across all samples is
considered as a stability measure and each microRNA
is weighted by its stability to generate the artificial
endogenous control levels.
Methods
The primary dataset used in this study was obtained
from a recently deposited microRNA RT-PCR dataset in
the Gene Expression Omnibus (GEO) [25]. The data
was from a study by Jukic et al. that examined the dif-
ference in miRNA expression profiles in melanocytic
neoplasms between young and older adults [1]. Their
study examined 10 young adults and 10 older adults
and measured the expression of 666 microRNAs. We
used the raw CT values measured in their data to com-
pare different approaches to normalizing the data. This
dataset has been previously used by Deo et al. to com-
pare various normalization techniques; this dataset is
highly suited to the comparison of normalization studies
due to the large number of samples and the use of mul-
tiple cards [23].
We have investigated several normalization methods,
including quantile, mean, and median normalization
methods, and endogenous controls identified using var-
ious stability criteria. In mean and median normaliza-
tion, the mean and median of all of the genes in a given
sample are used as the value for CT0. For identification
of endogenous controls, we calculate the standard devia-
tion of each microRNA across all samples, and rank
them in the order of increasing standard deviation. The
CT values of the top-k microRNAs are averaged in each
sample to provide the CT0 values.
A new weighted mean metric is proposed using the
standard deviations of the microRNAs as weights. For a
















where wmp is the weighted mean power, which can be
adjusted to shift the dominance between stable and
unstable microRNAs, n is the number of genes or
microRNAs, and STD is a function that returns the
standard deviation. The weighted mean calculation
involves raising the inverse of the standard deviation of
a given gene across all samples to the weighted mean
power, which is usually specified as 1, and dividing by
the sum of the inverses of the standard deviations for all
genes. CT0 is calculated for each sample by taking the
sum of the product of all the raw CT values in the sam-
ple and the previous number. When the ΔCT is calcu-
lated the CT of each gene is subtracted by the above
value. This method gives a higher weight to genes with
a lower standard deviation.
We also examined the reproducibility of miRNA expres-
sion experiments between RT-PCR and microarray.
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To explore this topic we utilized data from Chen et al.
[26]. They evaluated miRNA expression in murine myo-
blasts utilizing both RT-PCR and microarrays. They evalu-
ated the consistency of different RNA preparation
methods for RT-PCR. We harnessed their data to explore
the correlation of RT-PCR with microarray. We further
explored whether the expression level of a particular
miRNA in RT-PCR would bias its correlation with its
expression on a microarray.
Results and Discussion
In order to test the hypothesis that increasing CT values
magnifies the natural variation between the initial amounts
of samples loaded in each well during RT-PCR, we exam-
ined the standard deviation of the genes against their
mean CT values, as shown in Figure 1. The application of
linear regression to this data clearly shows a trend of
increasing standard deviation values for higher CT values.
Note that the higher the CT value, the more cycles were
required to observe that microRNA, hence the less abun-
dant that microRNA was in the initial loaded sample.
As expected, the CT values of most genes are well corre-
lated with the mean expression of all the genes. This is
illustrated in Figure 2, where we show the expression of
the 20 miRNAs that are most correlated with the mean
expression. Each tick on the x-axis represents a unique
experimental sample.
The correlation with the mean expression level extends
to low-abundant miRNAs. We demonstrate this in Figure
3, wherein the Pearson correlation coefficient of the fluc-
tuations in each gene with respect to its own average is
shown against the fluctuations of the mean expression
levels of all genes. The plot shows that a high correlation
is observed whether the mean CT values are low or high.
In order to quantify the sensitivity of the microRNA
expression levels to the initial loaded sample size, a regres-
sion line is fitted to the fluctuation of each miRNA against
the fluctuation of mean expression. Fluctuation is deter-
mined by subtracting the value of the expression of a
miRNA in a given sample from the mean expression of
that miRNA for all samples; the overall mean of the
expression of all miRNAs in all samples can be subtracted
from the sample means to determine the fluctuation of a
sample mean. In Figure 4 we demonstrated this for a sin-
gle miRNA. The x-value of each point is the difference
between a sample mean and the overall mean, and the y-
value is the difference between the expression of that par-
ticular miRNA in that sample and the mean expression of
that miRNA across all samples. The slope of the line indi-
cates how sensitive the miRNA is to initial sample size,
with larger slope values corresponding to larger variations
in response to a small change in sample size. The slopes
were calculated for all miRNAs. Figure 5 shows the sensi-
tivity of each miRNA, which is determined by the slope
Figure 1 Dependence of variability on expression level. Each point represents the standard deviation versus the mean of the CT values for a
particular microRNA across all samples.
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Figure 2 miRNAs most correlated with the mean expression value. The CT values of 20 miRNAs where the change between samples is
most correlated with the change in the mean expression value from sample to sample.
Figure 3 Correlation with mean vs. mean CT value. Each point represents the correlation of a particular miRNA with the mean expression of
all miRNAs across multiple samples vs. the mean of the CT value of that particular microRNA. The x-values are the mean CT of a miRNA, and
the y-values are the correlation of the vector of sample differences from the mean for each miRNA with the vector of the sample mean
differences from the overall mean.
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calculation demonstrated in Figure 4, versus against the
overall mean expression level of that miRNA. We observe
that the sensitivity is expression level dependent. Highly
expressed miRNAs (those with small CT values) are less
responsive to changes in the overall mean of the miRNAs,
whereas the low-abundant genes are more sensitive to the
changes in the overall mean of the miRNAs. Note that,
this is not simply a random effect due to low abundant
microRNAs being more variable, since the variation is still
correlated and is in the same direction of the change in
mean expression level. The same observation is made by
examining the ratio of the fluctuations in individual miR-
NAs to the fluctuations of the mean expression level, as
shown in Figure 6.
In conclusion, the fluctuations of the low-abundant
miRNAs are not random. The changes in their expres-
sion levels are correlated well with the overall changes in
all miRNAs, which is assumed to be due to different
starting sample sizes for the PCR reactions. We see that
there is a systematic bias in the CT values that causes the
expression levels of the low-abundant miRNAs to be
more sensitive to the initial sample sizes.
We then investigated the suitability of our weighted
mean metric. In Figure 7 we display the values for CT0
for several different methods including using the mean of
all raw CT values in the bottom line (top-k = 0), the
means of the top-k miRNAs for different values of k, and
the weighted mean for different values for the weighted
mean power. The plot demonstrates that varying the
weighted mean power enables the shifting of the curve
upwards or downwards. In Table 1 and Table 2, we com-
pare the resulting means, standard deviations, and geN-
orm stability values [27] for mean and weighted mean
normalizations, respectively. We repeat analysis this for
the top 10 genes, with the lowest standard deviation in 3.
We see slightly higher standard deviations in the
weighted mean normalization method compared to the
top-k calculations, but the weighted means’ CT0 values
are determined to be more stable by geNorm (the lower
the value the more stable). In Table 3, we see that the
best individual miRNAs have a much higher standard
deviation and are much less stable than any of the CT0
calculations using either the top-k miRNAs or the
weighted mean. This indicates that it is better to use
these values in the ΔΔCT calculation than any endogen-
ous control. We also investigated the use of the geo-
metric mean of the endogenous controls, all of the
miRNAs, or just the top-k miRNAs. In all cases using the
geometric mean resulted in similar but slightly lower
values for CT0 as using the mean and almost exactly the
Figure 4 Correlation of miRNA fluctuation with mean fluctuation. Each point represents a single sample in the study. The x-value of the
point is the difference of the sample mean from the overall mean and the y-value is the difference between the expression of an miRNA in that
sample and the mean expression of that miRNA across all samples. The slope of the line quantifies the sensitivity of fluctuations in the miRNA’s
value to fluctuations in the overall mean. This plot is presented as an example for a single microRNA; all miRNAs were plotted in this fashion.
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Figure 5 A plot of fluctuation response vs. expression level. Each point represents the slope of a particular miRNA as shown by example in
Figure 4. All miRNAs’ slopes are plotted against their mean CT to show that as CT increases the response to sample fluctuations also increases.
Figure 6 Difference ratio vs. expression level. Each point represents the ratio of the differences in expression level of a microRNA and the
mean of all microRNAs against the mean of the CT values for that particular microRNA across all samples. The difference ratio is calculated by
dividing the difference of a miRNA’s expression in a particular sample by the difference between that sample’s mean and the overall mean. For
each miRNA a vector of difference ratios is calculated with one value for each sample. On the figure the y-axis represents the mean difference
ratio for a particular miRNA. The ratio of this difference increases with increasing CT, demonstrating that lowly expressed miRNAs are more
sensitive to fluctuations in the mean.
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same standard deviations and geNorm stability values
(data not shown), thus using the geometric mean had no
advantage over using the mean.
The proposed weighted mean normalization method
could not be compared to quantile normalization in the
same fashion as the other methods because quantile
normalization does not have a value analogous to CT0
which could be evaluated for stability and compared to
weighted mean normalization. However, the normalized
data resulting from each method could be visualized and
compared as boxplots. Figure 8 shows the distributions
of the raw and normalized data. All normalization meth-
ods tend to decrease the variability compared to the raw
data. Although quantile normalization forces all samples
Figure 7 Comparison of the CT0 values generated by different normalization methods. The CT0 calculations of each normalization method
for each sample are shown here. The legend indicates the method used. The last number on the legend shows either the k value in a top-k
calculation for the mean normalizations or the weighted mean power for the weighted mean normalizations.
Table 1 Mean Normalization
top-k mean CT0 stdev geNorm
1 20.92 0.69 0.35
2 23.2 0.64 0.21
3 23.8 0.64 0.19
4 22.13 0.63 0.2
5 22.11 0.61 0.17
6 22.79 0.6 0.18
7 22.91 0.61 0.16
8 23.66 0.59 0.15
9 23.67 0.6 0.16
10 23.61 0.61 0.16
∞ 25.59 0.71 0.23
Mean CT0 calculations, standard deviations, and geNorm stability values for
using the mean of the top-k miRNAs with lowest standard deviation as the
CT0 value. An infinite value for k signifies the mean of all miRNAs. The best
values are marked in bold.
Table 2 Weighted Mean Normalization
power mean CT0 stdev geNorm
1 25.34 0.69 0.21
3 24.82 0.67 0.18
5 24.35 0.65 0.15
7 23.96 0.64 0.14
9 23.65 0.63 0.13
11 23.41 0.62 0.12
13 23.21 0.62 0.12
15 23.04 0.62 0.12
17 22.89 0.61 0.12
19 22.76 0.61 0.13
Mean CT0 calculations, standard deviations, and geNorm stability values for
weighted mean normalization using different values of the weighted mean
power.
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to have the same medians and distributions, Figure 8
shows that weighted mean normalization compares
favorably with quantile normalization. Although the sam-
ple medians and sample standard deviations resulting
from weighted mean normalization differ slightly, they
are generally uniform, and they are clearly more uniform
than the endogenous control normalization. Weighted
mean normalization also tends to have lower standard
deviation than quantile normalization. For three samples
in the second group (PM3, PM4, and PM5) that have
higher expression in the raw data, weighted mean nor-
malization results in medians and standard deviations
which are similar to the other samples, while quantile
normalization seems to produce greater standard devia-
tion for these samples.
Table 3 Using the top 10 miRNAs as endogenous
controls
miRNA mean CT0 stdev geNorm
191 20.92 0.69 1.14
744 25.49 0.72 1.17
152 25 0.73 1.12
MammU6 17.12 0.75 1.22
92a 22.03 0.75 1.24
29c 26.15 0.78 1.26
186 23.69 0.78 1.17
671-3p 28.89 0.8 1.29
26b 23.75 0.8 1.19
let-7d 23.07 0.8 1.16
Mean CT0 calculations, standard deviations, and geNorm stability values
resulting from using each of the 10 miRNAs with lowest standard deviation.
Figure 8 Boxplots of raw and normalized data. Here boxplots of the raw data in the first row, followed by boxplots of normalized data in
each subsequent row are presented. The raw CT values are compared to the quantile normalized CT values and the ΔCT values produced by
the endogenous controls and the weighted mean normalization with a weighted mean power of 13. The column on the left contains adult
melanoma samples, the middle column contains pediatric melanoma samples, and the right column contains adult and pediatric nevus samples.
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Having explored the problems of RT-PCR normaliza-
tion, the consistency of miRNA expression experiments
between RT-PCR and microarray technologies was of
further interest to us. In order to explore this issue we
used a dataset from Chen et al. [26], to explore the repro-
ducibility of miRNA expression experiments across dif-
ferent platforms. Chen et al. explored the effect of
different reverse transcription reactions as well as the
effect of pre-amplification of a sample. They concluded
that different reverse transcription reactions did not
result in significant variation in CT values. Because the
samples in their dataset were highly consistent, as shown
in Figure 9, this dataset was not suitable for the evalua-
tion of the different normalization methods presented in
this work. We instead examined the effect of initial con-
centration of a miRNA on its correlation with the micro-
array experiment. Figure 10 contains a plot of the ΔCT
value vs. the base 2 logarithm of the microarray expres-
sion for each miRNA for both cards in the experiment.
The microarray data was log-transformed so that it
would be on the same scale as the ΔCT values. We
expect the ΔCT values to correlate negatively with the
microarray values since lower ΔCT values indicate higher
expression, and Figure 10 shows that generally lower
ΔCT values are associated with higher microarray
expression.
Figure 11 displays the Spearman correlation of each of
the RT-PCR samples with the microarray data. The
experiment used two different arrays or cards for RT-PCR.
The card “A” contains well-characterized miRNAs, while
card “B” contains newly discovered, less well-known miR-
NAs [26]. We observe that card B is more highly corre-
lated than card A. However, card A had 134 miRNAs
detected that were also present on the microarray while
card B only detected 29 miRNAs that were present on the
microarray. Although the values are similar, the pre-ampli-
fied samples have a higher correlation with the microarray
than the non-amplified samples. Due to the bias described
previously we expected to observe miRNAs with higher
initial concentrations (lower CT values) to correlate better
with the microarray. In order to test this hypothesis we
partitioned the data from each card into bins based on CT
ranges. In card “A”, contrary to our expectation, we
observe that the Spearman correlation improves slightly
for higher CT values as shown in Figure 12. We also
observe that using all miRNAs results in a stronger corre-
lation than any individual range of CT values. In Card “B,”
shown in Figure 13, we do observe stronger correlation
values with lower CT ranges. The highest bin, containing
miRNAs with average CT values ranging from 30 to 35
contradicts the expectation of negative correlation, and we
observe a large positive correlation, however this correla-
tion is not significant, indicating that the measurement of
the expression of the specific miRNAs that fell in this
range exhibited considerable variability between RT-PCR
and microarray data.
Figure 9 Distribution of miRNA CT values on card A. Each line represents the CT value of a particular miRNA across each of the four
samples.
Qureshi and Sacan BMC Medical Genomics 2013, 6(Suppl 1):S14
http://www.biomedcentral.com/1755-8794/6/S1/S14
Page 10 of 13
Conclusions
We explored the phenomenon whereby differences in the
initial sample size of miRNA in an RT-PCR experiment
were magnified with increasing CT levels. This was illu-
strated by the strong correlation of the CT values of the
individual miRNAs with the average CT values of all miR-
NAs and by the increased sensitivity in the CT values of
the low-abundant miRNAs to the average CT values. We
conclude that a systematic bias in RT-PCR exists in which
the fluctuations in the CT are dependent on the
expression levels of the particular miRNAs. We further
proposed a novel data-driven method of addressing this
bias by using the weighted mean instead of an endogenous
control in the calculation of ΔCT. We demonstrated that
the new normalization method produces lower standard
deviations and is more stable than other methods.
Note that, while the power parameter in the weighted
mean normalization method provides a convenient way of
adjusting how much one wishes to let the less stable micro-
RNAs influence the normalization of other microRNAs, its
Figure 10 RT-PCR expression vs. log microarray expression. On the left each point represents the base 2 logarithm of the microarray
expression vs. the ΔCT value for a particular miRNA for card A. On the right is the same plot for card B.
Figure 11 Spearman correlation of each RT-PCR sample with microarray expression. Here we show the Spearman correlation of the ΔCT
values with the base 2 logarithm of microarray expression for each RT-PCR sample. The left four samples come from card A and consist of two
different reverse transcription reactions each performed on one of two different days. The right four samples come from card B and consist of
two pre-amplified and two non-amplified RT-PCR samples.
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Figure 12 Correlation of card A by range of CT values. Here we divided the miRNAs detected on both card A and the microarray into
ranges of CT values and calculated the Spearman correlation of the miRNAs’ ΔCT values with the base 2 logarithm of their microarray expression.
Figure 13 Correlation of card B by range of CT values. Here we divided the miRNAs detected on both card B and the microarray into
ranges of CT values and calculated the Spearman correlation of the miRNAs’ ΔCT values with the base 2 logarithm of their microarray expression.
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optimization currently requires enumeration of different
values and using the one with the best overall stability.
Several CT0 values can be calculated for different values
for the weighted mean power, subsequently the value of
the power that produces the lowest standard deviation or
is determined to be the most stable by geNorm can be
used for normalization. The standard deviation or geNorm
stability calculations are two methods to quantitatively
determine the ideal weighted mean power. Other criteria,
such as significance of the differentially expressed micro-
RNAs can be utilized in this optimization. Furthermore, a
different custom CT0 value for each microRNA may be
used, such that each microRNA is normalized differently,
dependent on its average expression level.
We further examined the reproducibility of miRNA
expression experiments across two different platforms by
comparing RT-PCR and microarray results. We explored
the relationship between the CT value and the consistency
of the expression of a miRNA between RT-PCR and
microarray. We leave as a future work the comparison of
the ability of different normalization methods to detect
differentially expressed genes.
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